Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 26, Issue 7, 2014, Pages 835-841

  Chakrapani, Venkatesan ^a   Velayudham, Jaikumar ^a   Shunmugam, Murali ^a   Newman, Peter A ^b   Dubrow, Robert ^c  

^a Centre for Sexuality and Health Research and Policy (C SHaRP)   (India)

^b UNIVERSITY OF TORONTO   (Canada)

^c YALE UNIVERSITY   (United States)

Author keywords

Access to health care; AIDS; Antiretroviral treatment; HIV; India; Injecting drug users

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; ATTITUDE; CLINICAL ARTICLE; CONFIDENTIALITY; DRUG DEPENDENCE TREATMENT; FAMILY; FEAR; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INTRAVENOUS DRUG ABUSE; MALE; MOTIVATION; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SELF CONCEPT; SOCIAL DISCRIMINATION; SOCIAL STIGMA;

ACCESS TO HEALTH CARE; AIDS; ANTIRETROVIRAL TREATMENT; HIV; INDIA; INJECTING DRUG USERS;

ADULT; ANTI-HIV AGENTS; COMORBIDITY; DRUG USERS; FEMALE; FOCUS GROUPS; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INDIA; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; SELF EFFICACY; SOCIAL STIGMA; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84899957892     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2013.861573     Document Type: Article

References (36)

1. Abraham, K. K., D'Costa, C., Shunmugam, M., & Chakrapani, V. (2007). India. In International Treatment Preparedness Coalition (ITPC) (Ed.), Missing the target #5: Improving AIDS drug access and advancing health care for all (pp.75-76). San Francisco, CA: The Tides Center. Retrieved from http://www.opensocietyfoundations.org/sites/default/ files/missing-20071201.pdf
2. Aceijas, C., Oppenheimer, E., Stimson, G. V., Ashcroft, R. E., Matic, S., & Hickman, M. (2006). Antiretroviral treatment for injecting drug users in Developing and transitional countries 1 year before the end of the 'Treating 3 million by 2005. Making it happen. The WHO strategy' ('3 by5'). Addiction, 101, 1246-1253. doi:10.1111/j.1360-0443.2006.01509.x
3. Aday, L. A., & Andersen, R. (1974). A framework for the study of access to medical care. Health Services Research, 9, 208-220
4. Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., & Moss, A. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435-442
5. Bassetti, S., Battegay, M., Furrer, H., Rickenbach, M., Flepp, M., Kaiser, L., Sudre, P. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?. Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 21, 114-119
6. Chakrapani, V. (2005). India. In International Treatment Preparedness Coalition (ITPC) (Ed.), Missing the target #1: A report on HIV/AIDS treatment access from the frontlines (pp. 25-38). Cape Town: ITPC. Retrieved from http://www.hivpolicy.org/Library/HPP001289.pdf
7. Chakrapani, V., Newman, P. A., Shunmugam, M., & Dubrow, R. (2011). Barriers to free antiretroviral treatment access among kothi-identified men who have sex with men and aravanis (transgender women) in Chennai, India. AIDS Care, 23, 1687-1694. doi:10.1080/09540121.2011.582076
8. Chakrapani, V., Newman, P. A., Shunmugam, M., Kurian, A. K., & Dubrow, R. (2009). Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS Patient Care and STDs, 23, 973-980. doi:10.1089/ apc.2009.0035
9. Charmaz, K. (2006). Constructing grounded theory: A practical guide through qualitative analysis. Thousand Oaks, CA: Sage
10. Clarke, S., Delamere, S., McCullough, L., Hopkins, S., Bergin, C., & Mulcahy, F. (2003). Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Medicine, 4(1), 33-37. doi:10.1046/j.1468-1293.2003.00130.x
11. Ding, L., Landon, B. E., Wilson, I. B., Wong, M. D., Shapiro, M. F., & Cleary, P. D. (2005). Predictors and consequences of negative physician attitudes toward HIV-infected injection Drug users. Archives of Internal Medicine, 165, 618-623. doi:10.1001/archinte.165.6.618
12. Escaffre, N., Morin, M., Bouhnik, A. D., Fuzibet, J. G., Gastaut, J. A., Obadia, Y., & Moati, J. P. (2000). Injecting drug users' adherence to HIV antiretroviral treatments: Physicians' beliefs. AIDS Care, 12, 723-730. doi:10.1080/ 09540120020014264
13. Gebo, K. A., Keruly, J., & Moore, R. D. (2003). Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. Journal of General Internal Medicine, 18(2), 104-111. doi:10.1046/j.1525-1497.2003.10801.x
14. Kerr, T., Marshall, A., Walsh, J., Palepu, A., Tyndall, M., Montaner, J., Wood, E. (2005). Determinants of HAART discontinuation among injection Drug users. AIDS Care, 17, 539-549. doi:10.1080/095401204123313 19778
15. Knowlton, A., Arnsten, J., Eldred, L., Wilkinson, J., Gourevitch, M., Shade, S., INSPIRE Team. (2006). Individual, interpersonal, and structural correlates of effective HAART use among urban active injection Drug users. 10.1097/01.qai.0000186392.26334.e3 Journal of Acquired Immune Deficiency Syndromes, 41, 486-492. doi:10.1097/01.qai.0000186392.26334.e3
16. Kumar, M. S., & Agrawal, A. (2012). Scale-up of opioid substitution therapy in India: Opportunities and challenges. International Journal of Drug Policy, 23, 169-170. doi:10.1016/j.drugpo.2011.11.002
17. Latkin, C., Srikrishnan, A. K., Yang, C., Johnson, S., Solomon, S. S., Kumar, S., Solomon, S. (2010). The relationship between Drug use stigma and HIV injection risk behaviors among injection Drug users in Chennai, India. Drug and Alcohol Dependence, 110, 221-227. doi:10.1016/j.druga lcdep.2010.03.004
18. Lincoln, Y. S., & Guba, E. (1985). Naturalistic enquiry. Newbury Park, CA: Sage
19. Maisels, L., Steinberg, J., & Tobias, C. (2001). An investigation of why eligible patients do not receive HAART. AIDS Patient Care and STDs, 15, 185-191. doi:10.1089/ 10872910151133701
20. Moatti, J. P., Carrieri, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., & Moreau, J. (2000). Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS, 14, 151-155. doi:10.1097/ 00002030-200001280-00010
21. National AIDS Control Organization [NACO]. (2006). Strategy and implementation plan -National AIDS Control Programme Phase III [2007-2012]. New Delhi: Ministry of Health and Family Welfare, Government of India
22. National AIDS Control Organization [NACO]. 2008 Standard operating procedure for oral substitution therapy with buprenorphine. New Delhi: Ministry of Health and Family Welfare, Government of India
23. Retrieved from http://www.unaids.org/en/dataana lysis/knowyourresponse/ ncpi/2012countries/India%20NCP I%202012.pdf
24. Rao, R., Agrawal, A., Kishore, K., & Ambekar, A. (2013). Delivery models of opioid agonist maintenance treatment in South Asia: A good beginning. Bulletin of World Health Organisation, 91, 150-153. doi:10.2471/BLT.12.111815
25. Ritchie, J., & Spencer, E. (1994). Qualitative data analysis for applied policy research. In A. Bryman & R. G. Burgess (Eds.), Analyzing qualitative data (pp. 173-194). London: Routledge
26. Sambamoorthi, U., Warner, L. A., Crystal, S., & Walkup, J. (2000). Drug abuse, methadone treatment, and health services use among injection Drug users with AIDS. Drug and Alcohol Dependence, 60, 77-89
27. Sharma, M., Singh, R. R., Laishram, P., Kumar, B., Nanao, H., Sharma, C., & Ahmed, T. (2007). Access, adherence, quality and impact of ARV provision to current and exinjecting drug users in Manipur (India): An initial assessment. International Journal of Drug Policy, 18, 319-325. doi:10.1016/j.drugpo.2007. 04.001
28. Solomon, S. S., Srikrishnan, A. K., Mehta, S. H., Vasudevan, C. K., Murugavel, K. G., Thamburaj, E., Celentano, D. D. (2008). High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection Drug users in Chennai, India: A cause for concern. Journal of Acquired Immune Deficiency Syndromes, 49, 327-332. doi:10.1097/QAI.0b013e3181831e85
29. Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage
30. Wainberg, F. M. A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977-1983. doi:10.1001/jama.279.24.1977
31. Wolfe, D. (2007). Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence and structural barriers in Asia and the former Soviet Union. International Journal of Drug Policy, 18, 246-254. doi:10.1016/j.drugpo.2007.01.012
32. Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376, 355-366. doi:10.1016/S0140-6736(10)60832-X
33. Wood, E., Hogg, R. S., Kerr, T., Palepu, A., Zhang, R., & Montaner, J. S. (2005). Impact of accessing methadone on the time to initiating HIV treatment among antiretroviralnaive HIV-infected injection Drug users. AIDS, 19, 837-839. doi:10.1097/01.aids.0000168982.20456.eb
34. Wood, E., Kerr, T., Tyndall, M. W., & Montaner, J. S. (2008). A review of barriers and facilitators of HIV treatment among injection Drug users. AIDS, 22, 1247-1256. doi:10.1097/QAD.0b013e3282fbd1ed
35. World Health Organization. (2004). Guidance on ethics and equitable access to HIV treatment and care. Geneva: Author
36. World Health Organization Regional Office for Europe. (2007). HIV/AIDS treatment and care for injecting drug users. Clinical protocol for the WHO European region. Copenhagen: Author.